Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133881) titled 'A Study on the Efficacy of Different Treatment Regimens for IgA Nephropathy and Their Effects on Serum Biomarkers (Gd-IgA1 and sCD89)' on Oct. 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: second hospital of shanxi medical university
Condition:
IgA Nephropathy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-15
Target Sample Size: Observation group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=344225
Disclaimer: Curated by HT Syndication....